Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BREAKING NEWS: CRISPR/Cas9 is at it again


BREAKING NEWS: CRISPR/Cas9 is at it again. No longer content as only a genomic editing tool, CRISPR/Cas9 can also edit the epigenome, per a new study published April 6 in Nature Biotechnology. The new technology utilizes non-cutting dCas9 protein coupled to a histone-modifying protein, creating a system able to selectively raise levels of gene expression by increasing activity at a variety of regulatory regions.

Enzo’s Newest Antibody: Monoclonal Antibody Cas9, mAb (7A9)
  • Recognizes both Cas9 and dCas9
  • Species independent detection
  • Validated for IF, IP and WB
  • Test additional applications Worry-Free!

Given the new advances, where do you think initial interest will lie? What would you like to edit in the epigenome? Tell us about it!

 
comments powered by Disqus

follow Us!

 

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,